Eating a Meal Reveals Hidden Heart Obstruction That Standard Tests Miss

For decades, patients with hypertrophic cardiomyopathy have told their doctors that their symptoms worsen after eating. A new narrative review, published in Echo Research & Practice, brings that clinical observation into sharp focus: measuring the pressure gradient across the left ventricular outflow tract after a meal detects obstructive physiology that conventional provocative maneuvers frequently miss. Across seven studies published between 1991 and 2024, postprandial echocardiography consistently provoked higher gradients than fasting measurement, and in the most rigorous comparative study it identified obstruction in 74 percent of patients who had none at rest, compared with 23 percent detected by the Valsalva maneuver.

Hypertrophic cardiomyopathy is the most common inherited cardiac disorder, with an estimated prevalence of roughly one in 500 people. Its hallmark complication, dynamic left ventricular outflow tract obstruction, defined as a peak instantaneous gradient of 30 mmHg or greater, affects about two-thirds of patients either at rest or under provocation and is a major determinant of symptoms and treatment decisions. Approximately one-third of patients obstruct at rest, another third only under provocative conditions, and the remainder do not obstruct under any tested condition. That distinction carries real consequences: obstructive physiology determines eligibility for septal reduction therapy and, more recently, for cardiac myosin inhibitor drugs, a class approved for symptomatic obstructive disease.

Current guidelines recommend provocative testing with the Valsalva maneuver, exercise echocardiography, or pharmacologic agents when resting obstruction is absent. Yet the review’s authors, led by Mahesh Chandrasekhar and Richard Brandon Stacey, note that a substantial proportion of patients report symptom exacerbation specifically after meals, an observation documented in the clinical literature for more than three decades. Eating lowers systemic vascular resistance and afterload while raising adrenergic tone, changes that promote systolic anterior motion of the mitral valve and dynamic obstruction. Despite this physiologic rationale, postprandial assessment has never been incorporated into standard evaluation, and the available evidence had not been synthesized until now.

The review team searched PubMed/MEDLINE, Embase, the Cochrane Library, and Web of Science from inception through June 2025. The search identified 247 records, of which seven met inclusion criteria. The authors had initially planned a PRISMA-style systematic review with meta-analysis, but the small number of eligible studies and the heterogeneity of their protocols and outcome measures did not support quantitative pooling, so they performed a narrative synthesis instead. The review was not prospectively registered. Eligible studies had to enroll patients with confirmed hypertrophic cardiomyopathy, compare outflow tract measurements between fasting and postprandial states, report quantitative data, and include at least ten patients. Case reports, small series, reviews, editorials, and pediatric studies were excluded.

The seven included studies were conducted in the United Kingdom, the United States, and Italy. Four were prospective cohorts, two were cross-sectional, and one combined invasive hemodynamic monitoring with echocardiography. Sample sizes ranged from 11 to 252 patients, and all seven scored seven or higher on the Newcastle-Ottawa Scale, the threshold the authors set for high quality. Six of the seven were conducted at dedicated hypertrophic cardiomyopathy referral centers. Meal protocols varied widely: two studies used a standardized 740 kcal mixed meal, while the rest used meals of variable or unspecified composition. Assessment timing ranged from 15 to 60 minutes after eating, and patient positioning evolved from supine rest in the earlier studies to upright standing with exercise and, ultimately, treadmill stress echocardiography.

The quantitative findings were striking. La Canna and colleagues enrolled 92 patients with no resting obstruction and measured the gradient under fasting, postprandial, and provoked conditions. Postprandial assessment identified a gradient of 30 mmHg or greater in 68 of 92 patients, or 74 percent, compared with 23 percent by Valsalva and 33 percent by exercise, a difference that was statistically significant. Massera and colleagues reported the largest cohort, 252 patients without known obstruction who underwent postprandial resting and treadmill stress echocardiography after a non-standardized meal. The median resting gradient rose from 0 mmHg fasting to 9.0 mmHg after eating. Among patients who did not reach the 50 mmHg threshold under routine conditions, an additional 35.7 percent reached it with postprandial assessment, and a further 15.1 percent reached it only with postprandial stress echocardiography.

Feiner and colleagues applied postprandial standing exercise echocardiography to 20 patients who had already tested negative on conventional fasting exercise testing. Thirteen of the 20, or 65 percent, developed significant obstruction, with the median gradient rising from 25 mmHg fasting to 61 mmHg after postprandial exercise. The authors caution, however, that this cohort was selected specifically for prior negative conventional testing, so its detection rate cannot be compared directly with the other studies. Adams and colleagues observed smaller changes after a standardized meal, with the mean gradient increasing by 5.0 plus or minus 8.3 mmHg in symptomatic patients versus 0.7 plus or minus 1.1 mmHg in controls, and the difference between symptomatic and asymptomatic patients was not statistically significant. An earlier study by Gilligan found postprandial increases in outflow tract velocity in both symptomatic and asymptomatic patients, with greater absolute velocities in the symptomatic group.

The mechanistic foundation comes from the only invasive hemodynamic data in this literature. Gilligan and colleagues studied 11 patients before and 45 minutes after a standardized 740 kcal meal. The systemic vascular resistance index fell by 17 percent, while mean right atrial pressure rose by 31 percent, mean pulmonary artery pressure by 14 percent, and pulmonary capillary wedge pressure by 17 percent, all statistically significant. The cardiac index rose by 18 percent, driven by an increase in heart rate without a significant change in stroke volume. This combination lowers afterload and shortens diastolic filling, conditions that favor systolic anterior motion of the mitral valve and dynamic obstruction. By contrast, the Valsalva maneuver produces a transient reduction in preload that depends heavily on patient effort and examiner technique, whereas the postprandial state is a sustained physiologic change that more closely reproduces the conditions under which patients become symptomatic.

The clinical stakes are considerable. In the Gilligan symptom study, more than one-third of 70 patients reported postprandial symptom exacerbation, and these patients were more symptomatic overall, with greater angina frequency and reduced exercise capacity. Feiner reported that 12 of 13 patients with postprandial obstruction had attributable symptoms; nine received targeted therapy with beta-blockers, disopyramide, or myectomy, and quality-of-life scores improved from 29 to 12 on the scale used. In the Massera cohort, among 71 patients treated, 32, or 45.1 percent, had obstruction of 50 mmHg or greater identified only after eating, meaning nearly half of treated patients would have been classified as having no obstruction on conventional assessment alone. Because cardiac myosin inhibitors are indicated only when obstruction is documented, and septal reduction requires documented gradients, a patient whose obstruction appears only after a meal may be denied a therapy from which they would benefit.

The authors are careful about the limits of the evidence. Most studies came from specialized referral centers with sonographers experienced in upright and post-exercise imaging, and the results may not transfer directly to less specialized settings. With the exception of the Massera cohort, the studies were small, no study reported long-term outcomes, and the predominance of positive findings in a small literature raises the possibility of publication bias. The heterogeneity of meal protocols also limits translation: significant obstruction was provoked with both standardized 740 kcal meals and patient-directed eating, suggesting the effect does not depend on precise meal composition, but no single meal composition, caloric threshold, or assessment time can yet be recommended. The review concludes that standardized multicenter validation is needed, and that questions about where postprandial testing belongs in the diagnostic sequence, and whether treatment response differs between patients identified by postprandial versus conventional assessment, remain open. In the meantime, the existing evidence supports consideration of postprandial testing in symptomatic patients who remain without obstruction on conventional evaluation, particularly those who report symptoms after meals.

Subject of Research: Postprandial echocardiographic assessment of left ventricular outflow tract obstruction in hypertrophic cardiomyopathy

Article Title: First we feast: a narrative review of postprandial assessment of left ventricular outflow tract obstruction in hypertrophic cardiomyopathy

Article References: Chandrasekhar, M., Park, C., Burgess, P., & Stacey, R. B. (2026). First we feast: a narrative review of postprandial assessment of left ventricular outflow tract obstruction in hypertrophic cardiomyopathy. Echo Research & Practice, 13(1), Article 32. https://doi.org/10.1186/s44156-026-00135-1

Image Credits: AI Generated

DOI: 10.1186/s44156-026-00135-1

Keywords: hypertrophic cardiomyopathy, left ventricular outflow tract obstruction, postprandial echocardiography, Valsalva maneuver, cardiac myosin inhibitors, narrative review, hemodynamics, systolic anterior motion, septal reduction therapy, diagnostic yield, echocardiography, First